FOLD Q3 2021 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$80M+18.0% YoY

Gross Profit

$68M85.3% margin

Operating Income

-$42M-53.3% margin

Net Income

-$50M-63.2% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

+2.8%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$25M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$957M

Total Liabilities

$580M

Stockholders' Equity

$377M

Cash & Equivalents

$386M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$80M	$67M	+18.0%
Gross Profit	$68M	$59M	+14.9%
Operating Income	-$42M	-$53M	+19.6%
Net Income	-$50M	-$64M	+21.4%

Geographic Segments

Non-US

$54M68%

UNITED STATES

$26M32%